Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Cash Flow PerformanceFair Value
Percentile Rank22
Studio
Year-over-Year Change

Free cash flow yield

Latest
-19.91%
↑ 25% vs avg
Percentile
P22
Within normal range
Streak
1 yr
Consecutive growthFair Value
Average
-26.65%
Historical baseline
PeriodValueYoY Change
2025-19.91%+88.2%
2024-168.08%-1332.6%
2023-11.73%+41.8%
2022-20.17%-75.6%
2021-11.49%-4.4%
2020-11.01%-55.1%
2019-7.10%+54.5%
2018-15.60%-1431.2%
2017-1.02%-184.5%
2016-0.36%-